These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31976783)

  • 1. A SEER population analysis of stage IB resected gastric cancer: who can benefit from adjuvant therapy?
    Wang Y; Guo S; Zhang J; Meng XY; Zheng ZC; Zhao Y
    Scand J Gastroenterol; 2020 Feb; 55(2):193-201. PubMed ID: 31976783
    [No Abstract]   [Full Text] [Related]  

  • 2. Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis.
    Wang Y; Zhang J; Guo S; Dong Z; Meng X; Zheng G; Yang D; Zheng Z; Zhao Y
    Clin Transl Oncol; 2019 Nov; 21(11):1499-1509. PubMed ID: 30903518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.
    Che K; Liu F; Wu N; Liu Q; Yuan L; Wei J
    Cancer Med; 2020 Oct; 9(19):7137-7150. PubMed ID: 32810384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer-an east and west multicenter study.
    Huang ZN; Desiderio J; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Lin JL; Zheng HL; Huang CM
    BMC Gastroenterol; 2019 Dec; 19(1):205. PubMed ID: 31791240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The addition of chemoradiation to adjuvant chemotherapy is associated with improved survival in lymph node-positive gastric cancer.
    Altman AM; Sheka AC; Marmor S; Lou E; Reynolds M; Hui JYC; Tuttle TM; Jensen EH; Denbo JW
    Surg Oncol; 2020 Sep; 34():134-139. PubMed ID: 32891318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.
    Li Y; Zhu Z; Ma F; Xue L; Tian Y
    Cancer Med; 2020 Sep; 9(18):6617-6628. PubMed ID: 32744431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel nomogram for identifying candidates for adjuvant chemotherapy in patients with stage IB gastric adenocarcinoma.
    Xie Y; Song X; Du D; Jin H; Li X; Ni Z; Huang H
    BMC Gastroenterol; 2023 Mar; 23(1):54. PubMed ID: 36879203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
    Li H; Wang Z; Yang F; Wang J
    J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nomogram for prediction of stage III/IV gastric cancer outcome after surgery: A multicenter population-based study.
    Gao Z; Ni J; Ding H; Yan C; Ren C; Li G; Pan F; Jin G
    Cancer Med; 2020 Aug; 9(15):5490-5499. PubMed ID: 32543092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort.
    Zuo Z; Zhang G; Song P; Yang J; Li S; Zhong Z; Tan Q; Wang L; Xue Q; Gao S; Sun N; He J
    Ann Surg Oncol; 2021 Jul; 28(7):3941-3950. PubMed ID: 33249521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a nomogram for predicting overall survival of gastric cancer patients after D2R0 resection.
    Zhang PF; Du ZD; Wen F; Zhang FY; Zhang WH; Luo L; Hu JK; Li Q
    Eur J Cancer Care (Engl); 2020 Sep; 29(5):e13260. PubMed ID: 32489013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
    Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
    Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
    Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
    BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.
    Wang CY; Yang J; Zi H; Zheng ZL; Li BH; Wang Y; Ge Z; Jian GX; Lyu J; Li XD; Ren XQ
    BMC Cancer; 2020 Jan; 20(1):10. PubMed ID: 31906882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis.
    Wang ZX; Yang XL; He MM; Wang F; Zhang DS; Li YH; Zhou ZW; Zhan YQ; Xu RH
    Medicine (Baltimore); 2016 Apr; 95(16):e3214. PubMed ID: 27100411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States.
    Datta J; McMillan MT; Ruffolo L; Lowenfeld L; Mamtani R; Plastaras JP; Dempsey DT; Karakousis GC; Drebin JA; Fraker DL; Roses RE
    Ann Surg Oncol; 2016 Sep; 23(9):2936-45. PubMed ID: 27090793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a prognostic nomogram in gastric cancer with hepatitis B virus infection.
    He Y; Mao M; Shi W; He Z; Zhang L; Wang X
    J Transl Med; 2019 Mar; 17(1):98. PubMed ID: 30909980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Nomogram to Predict the Overall Survival of Patients With Resected T1-2N0-1M0 Non-Small Cell Lung Cancer and to Identify the Optimal Candidates for Adjuvant Chemotherapy in Stage IB or IIA Non-Small Cell Lung Cancer Patients.
    Wang W; Zhou J
    Cancer Control; 2023; 30():10732748231197973. PubMed ID: 37703536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are the indications for postoperative radiotherapy in the NCCN guidelines for patients with gastric adenocarcinoma too broad? A study based on the SEER database.
    Huang ZN; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Lin JL; Zheng HL; Huang CM
    BMC Cancer; 2018 Nov; 18(1):1064. PubMed ID: 30390644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
    Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
    Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.